2-tert-butylhydroquinone has been researched along with cyclin d1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, X; Gao, XH; Li, B; Li, J; Li, W; Sun, G; Xing, X; Zhang, Y; Zhao, L | 1 |
1 other study(ies) available for 2-tert-butylhydroquinone and cyclin d1
| Article | Year |
|---|---|
Antioxidant tert-butylhydroquinone ameliorates arsenic-induced intracellular damages and apoptosis through induction of Nrf2-dependent antioxidant responses as well as stabilization of anti-apoptotic factor Bcl-2 in human keratinocytes.
Topics: Antioxidants; Apoptosis; Arsenic; bcl-2-Associated X Protein; Catalase; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Cytoplasm; Heme Oxygenase-1; Humans; Hydroquinones; Keratinocytes; Mitochondria; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase | 2016 |